Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.
Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE.
Laflamme MA, et al. Among authors: chen ky, chen y.
Nat Biotechnol. 2007 Sep;25(9):1015-24. doi: 10.1038/nbt1327. Epub 2007 Aug 26.
Nat Biotechnol. 2007.
PMID: 17721512